Akademiliv

Sahlgrenska akademins nyheter

På Svenska
University of Gothenburg Logotype
  • News
  • Notices
  • Calendar
  • Grants
  • About Akademiliv

New prostate cancer diagnostic pathway paves way for general screening

8 December, 2022 Leave a Comment

NEW STUDY. In screening for prostate cancer, the risk of overdiagnosis can be halved, a University of Gothenburg study shows. With the diagnostic pathway that has now been tried out, considerably fewer harmless tumors are found. This solves a big problem and makes general screening feasible.

Researchers at Sahlgrenska Academy, part of Gothenburg University, and Sahlgrenska University Hospital performed the present study, which is now published in The New England Journal of Medicine.

It focuses on a major problem in screening for prostate cancer: a very high proportion of the cancer cases detected represent small, usually harmless tumors. This carries a risk of many men being treated unnecessarily, with the associated risk of permanent complications in the form of urinary incontinence and impotence — effects that adversely affect their quality of life.

Focus on targeted tissue samples

In the present study, 37,887 men in Sweden aged 50–60 years were invited to take the prostate-specific antigen (PSA) blood test. In the event of their PSA levels being elevated, they were offered magnetic resonance imaging (MRI) of the prostate. The 17,980 men who took part (47 percent of all invitees) were divided into two groups.

In the reference group, all those with elevated PSA levels ​​were offered systematic tissue sampling, with 12 “blind” tissue samples taken from various parts of the prostate. If the MRI showed anything suspicious, another three or four targeted tissue samples were taken in the area concerned. Today this strategy is, broadly speaking, standard worldwide.

In the experimental group, only men with suspicious findings revealed by MRI were selected for tissue sampling. Four targeted tissue samples only were taken in the area of suspicion.

The results show that the risk of finding an indolent (harmless) cancer was halved in the experimental group, while serious, potentially deadly cancers were found on an almost equal scale in both groups.

Screening medically justified

The researcher in charge of the study was Jonas Hugosson, Professor of Urology at the University of Gothenburg and senior physician at Sahlgrenska University Hospital.

Jonas Hugosson, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg.
Photo: Johan Wingborg

“We must get away from the blind sampling of tissues that’s still standard today, rely on the MRI examination, and thus switch diagnostics to taking samples only in those men in whom MRI has depicted tumors — and then only do targeted samples in the area involved,” Hugosson says.

“This strategy is sharply reducing the number of people who need to undergo tissue sampling, which is an unpleasant procedure with an associated risk of infection. What’s more, the strategy halves the risk of detecting a harmless tumor, which has been the biggest obstacle to introducing general screening for prostate cancer,” he continues.

In the experimental group, there was a greater probability that detection of a moderately severe cancer would be slightly delayed in a small proportion of individuals. Nevertheless, the overall result indicates that there are now sound medical arguments for introducing screening in line with the current model.

“The results from this study can pave the way for the introduction of general screening for prostate cancer. But assessment must include also other factors, such as costs and access to MRI scans,” Hugosson concludes.

Title: Prostate Cancer Screening with PSA and MRI Followed by Targeted Biopsy Only

By: Elin Lindström
Tagged With: Ny studie, Ny studie, vetenskaplig publicering

Leave a Comment Cancel reply

Your email address will not be published. Required fields are marked *

Add your own events in the Akademiliv Calendar

No newsletter during the sports holiday – Wednesday, February 15

Information from Sahlgrenska Academy Research Support Office

[UPDATED JAN 24]
The Sahlgrenska Academy Research Support Office provides an overview of upcoming and current calls, nominations and events in an information letter. This letter is updated approximately four times per semester.

’20 minutes for researchers’ is back – see full spring program

During 20 minutes over Zoom, the Biomedical Library gives tips on tools and services that can facilitate your research everyday life.

We are building at Medicinareberget

You will now find comprehensive information on construction projects that affect the Sahlgrenska Academy in the Staff Portal.

Lunch menus

Café Anatomen
Menu not available on website.

Café Annedal
Menu not available on website.

Lunchen.nu

Lustgården på Änggårdsbacken
Take away for external guests between 11.00-12.30 weekdays.

Lyktan

Mersmak Mölndal

Mersmak Sahlgrenska

Mersmak Östra

Salt & Syra

More news

Nytt ansökningsförfarande för SSMF Starting och Consolidator Grant

7 February, 2023

ANNOUNCEMENTS. Starting this year, SSMF is introducing a new application procedure for its Starting and Consolidator Grant calls. These will now …  

The master’s program in public health paved the way for collaboration in Sri Lanka and India

7 February, 2023

TRAVELOGUE. In early November last year, Solveig Lövestad and Monica Hunsberger (Master’s program in public health Directors) and Evelina Nyström …  

Use of methotrexate is associated with an increased risk of skin cancer

7 February, 2023

NEW STUDY. The immunosuppressive drug methotrexate (MTX) can be linked to an elevated risk of three types of skin cancer, a new study by …  

Distinct gender norms in descriptions of chronic pain

6 February, 2023

DOCTORAL THESIS. Sensitive women and stoical men are the prevalent images of people in chronic pain. Unwarranted differences in medical treatment …  

New thesis: Higher risk of future accidental bowel leakage after sphincter injury

3 February, 2023

THESIS. A study that was part of a recent doctoral thesis at the Institute of Clinical Sciences reports a significantly higher risk of developing …  

Formal ceremony for Zealous and Devoted Service

3 February, 2023

ACADEMIC CEREMONIES. On Wednesday, January 25, the University invited a 68 staff members to a ceremony to receive their Zealous and Devoted …  

Nominations for Honorary Doctors 2023 is open

2 February, 2023

HONORARY DOCTOR. All staff at Sahlgrenska Academy may nominate honorary doctorates. The appointments are evidence of the faculty’s appreciation, a …  

Depression and low quality of life 30 years after chemical attack

27 January, 2023

NEW STUDY. Mustard gas harms the vision, skin and breathing. Three decades on, however, the predominant effect is mental ill-health. At a time …  

Testing a immunological drug as a new treatment for early type 1 diabetes

26 January, 2023

CLINICAL STUDY. A large clinical study is now beginning on an approved drug for treating psoriasis. The drug will be tested on patients who were …  

Emma Eckernäs: GU now surveying doctoral students’ work environment too

25 January, 2023

COLUMN. For the first time, the work environment survey (ARK) at the University of Gothenburg (GU) now contains a sub-survey aimed specifically …  

More news...

Sahlgrenska Academy

© University of Gothenburg
PO-Box 100, S-405 30 Gothenburg, Sweden
Phone: 00 46 31 786 0000

About the website

Elin Lindström is editor for Akademiliv.
Please feel free to send your ideas and comments to akademiliv@gu.se

Sign up for the Akademiliv newsletter:

Send you tips to Akademiliv

Do you have a suggestion for news, grants, seminars or an education?
Send an email to Elin Lindström Claessen